For the year ending 2025-12-31, MRNA has $12,338M in assets. $3,688M in debts. $2,595M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,595 | 1,927 | 2,907 | 3,205 |
| Investments | 3,204 | 5,098 | 5,697 | 6,697 |
| Accounts receivable, net | 184 | 358 | 892 | 1,385 |
| Inventory | 153 | 117 | 202 | 949 |
| Prepaid expenses and other current assets | 408 | 599 | 627 | 1,195 |
| Total current assets | 6,544 | 8,099 | 10,325 | 13,431 |
| Investments, non-current | 2,336 | 2,494 | 4,677 | 8,318 |
| Property, plant and equipment, net | 2,134 | 2,196 | 1,945 | 2,018 |
| Right-of-use assets, operating leases | 719 | 759 | 713 | 121 |
| Deferred tax assets | - | - | 81 | 982 |
| Other non-current assets | 605 | 594 | 685 | 988 |
| Total assets | 12,338 | 14,142 | 18,426 | 25,858 |
| Accounts payable | 317 | 405 | 520 | 487 |
| Accrued liabilities | 1,386 | 1,427 | 1,798 | 2,101 |
| Deferred revenue | 99 | 153 | 568 | 2,038 |
| Income taxes payable | - | - | 63 | 48 |
| Other current liabilities | 185 | 221 | 66 | 249 |
| Total current liabilities | 1,987 | 2,206 | 3,015 | 4,923 |
| Deferred revenue, non-current | 153 | 58 | 83 | 673 |
| Operating lease liabilities, non-current | 653 | 671 | 643 | 92 |
| Financing lease liabilities, non-current | 20 | 39 | 575 | 912 |
| Long-term debt | 590 | - | - | - |
| Other non-current liabilities | 285 | 267 | 256 | 135 |
| Total liabilities | 3,688 | 3,241 | 4,572 | 6,735 |
| Additional paid-in capital | 1,382 | 866 | 371 | 1,173 |
| Accumulated other comprehensive income (loss) | 45 | -10 | -123 | -370 |
| Retained earnings | 7,223 | 10,045 | 13,606 | 18,320 |
| Total stockholders equity | 8,650 | 10,901 | 13,854 | 19,123 |
| Total liabilities and stockholders equity | 12,338 | 14,142 | 18,426 | 25,858 |
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA)